What Are Disease-State Biospecimens?

Biospecimens such as fluids, tissues, and cells are collected from patients, most often obtained during the treatment process – a diagnostic test or a surgery. HemaCare has partnered with a leading global provider of human biological materials to supply clients with disease-state samples in fresh, frozen, and FFPE formats. With one of the world’s largest networks of ethically approved human biospecimens, you now have access to high-quality, well-characterized materials from a wide range of disease types that can be sourced with short turnaround times to advance your research and development project on your timelines. Biospecimen samples include data on past treatments, demographic profiles, medical conditions and histories, and medications.

Why Use Disease-State Biospecimens

By comparing the various properties of biospecimens from patients with specific diseases versus healthy samples, scientists gain valuable insights into the disease etiology. Biospecimens are also typically used to identify and validate ways to deliver drugs or agents to specific cells, study the development and progression of diseases, and develop screening tests to detect biomarkers. Disease-state biospecimens are an essential resource for research and can lead to important medical discoveries for life-threatening diseases.

How Are Disease-State Biospecimens Collected?

Through our partnership with a leading global provider of disease-state biospecimens, you have access to a vast network of post-mortem and surgical excess biospecimens. All samples are ethically acquired from fully, IRB-consented donors for research use.